These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 6685828)

  • 21. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
    Wendorf KA; Winter K; Zipprich J; Schechter R; Hacker JK; Preas C; Cherry JD; Glaser C; Harriman K
    Clin Infect Dis; 2017 Jul; 65(2):226-232. PubMed ID: 28387784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
    Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further epidemiological investigations on subacute sclerosing panencephalitis (SSPE) in Romania.
    Cernescu C; Milea S
    Virologie; 1980; 31(3):173-82. PubMed ID: 6254241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subacute sclerosing panencephalitis (SSPE) in Poland in the years 1993-1995. The sixth stage of epidemiological research].
    Naruszewicz-Lesiuk D; Iwińska-Buksowioz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Przegl Epidemiol; 1997; 51(4):371-80. PubMed ID: 9562784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
    Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea.
    Takasu T; Mgone JM; Mgone CS; Miki K; Komase K; Namae H; Saito Y; Kokubun Y; Nishimura T; Kawanishi R; Mizutani T; Markus TJ; Kono J; Asuo PG; Alpers MP
    Epidemiol Infect; 2003 Oct; 131(2):887-98. PubMed ID: 14596530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subacute sclerosing panencephalitis: incidence among ethic groups in Israel.
    Soffer D; Rannon L; Alter M; Kahana E; Feldman S
    Isr J Med Sci; 1975 Jan; 11(1):1-4. PubMed ID: 1116935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subacute sclerosing panencephalitis in The Netherlands--1976-1990.
    Beersma MF; Galama JM; Van Druten HA; Renier WO; Lucas CJ; Kapsenberg JG
    Int J Epidemiol; 1992 Jun; 21(3):583-8. PubMed ID: 1634322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles and mumps immunization: benefit versus risk factors.
    Krugman S
    Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prospects of measles and subacute sclerosing panencephalitis (SSPE) elimination in Poland].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska-Buksowicz B; Kulczycki J
    Neurol Neurochir Pol; 1999; 33(3):653-63. PubMed ID: 10540725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subacute sclerosing panencephalitis in children: prevalence in South China.
    Ip P; Chung BH; Wong VC; Chan KY
    Pediatr Neurol; 2004 Jul; 31(1):46-51. PubMed ID: 15246492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing epidemiological features of subacute sclerosing panencephalitis.
    Anlar B; Köse G; Gürer Y; Altunbaşak S; Haspolat S; Okan M
    Infection; 2001 Aug; 29(4):192-5. PubMed ID: 11545478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subacute sclerosing panencephalitis (SSPE) in Poland in 1996-1999. Phase VII of epidemiologic studies].
    Naruszewicz-Lesiuk D; Iwińska-Buksowicz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Neurol Neurochir Pol; 2000; 34(5):877-85. PubMed ID: 11253477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult-onset subacute sclerosing panencephalitis: case reports and review of the literature.
    Singer C; Lang AE; Suchowersky O
    Mov Disord; 1997 May; 12(3):342-53. PubMed ID: 9159729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles vaccine efficacy in children previously vaccinated at 12 months of age.
    Marks JS; Halpin TJ; Orenstein WA
    Pediatrics; 1978 Dec; 62(6):955-60. PubMed ID: 733423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan--the second report 1977-1999].
    Hirayasu K; Nakada Y; Oshiro S; Takaesu E; Nakamura K; Shiroma N; Minema H
    No To Hattatsu; 2004 Jan; 36(1):21-5. PubMed ID: 14737859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan (1977-2005)].
    Hirayasu K; Oshiro S; Nakada Y
    No To Hattatsu; 2010 Nov; 42(6):427-31. PubMed ID: 21077352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High risk of subacute sclerosing panencephalitis following measles outbreaks in Georgia.
    Khetsuriani N; Sanadze K; Abuladze M; Tatishvili N
    Clin Microbiol Infect; 2020 Jun; 26(6):737-742. PubMed ID: 31707133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan, 1970-1996].
    Hirayasu K; Nakada Y; Takaesu E; Kamiya K; Hirayama K
    No To Hattatsu; 1999 Jan; 31(1):27-31. PubMed ID: 10025131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.